Praxsyn Corporation (PXYN) financial statements (2021 and earlier)

Company profile

Business Address 1803 SKY PARK CIRCLE
IRVINE, CA 92614
State of Incorp. IL
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2014
12/31/2013
12/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments100
Cash and cash equivalents100
Receivables9  
Inventory, net of allowances, customer advances and progress billings0
Inventory0  
Prepaid expense 0
Prepaid expense and other current assets0
Other current assets0 
Other undisclosed current assets2  
Total current assets:1200
Noncurrent Assets
Property, plant and equipment000
Long-term investments and receivables4  
Accounts and financing receivable, after allowance for credit loss4  
Other noncurrent assets0 
Deferred tax assets, net1  
Total noncurrent assets:500
TOTAL ASSETS:1700
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:922
Accounts payable0  
Accrued liabilities7  
Interest and dividends payable2  
Settlement liabilities0
Other undisclosed accounts payable and accrued liabilities 22
Debt(4)11
Derivative instruments and hedges, liabilities  0
Due to related parties0  
Disposal group, including discontinued operation1  
Deferred revenue and credits0  
Other undisclosed current liabilities811
Total current liabilities:1543
Noncurrent Liabilities
Long-term debt and lease obligation0  
Long-term debt, excluding current maturities0  
Liabilities, other than long-term debt0  
Accounts payable and accrued liabilities0  
Other undisclosed noncurrent liabilities(0) 0
Total noncurrent liabilities:0 0
Total liabilities:1543
Stockholders' equity
Stockholders' equity attributable to parent2(4)(3)
Treasury stock, value(0)  
Additional paid in capital541612
Accumulated deficit(52)(20)(15)
Total stockholders' equity:2(4)(3)
TOTAL LIABILITIES AND EQUITY:1700

Income statement (P&L) ($ in millions)

12/31/2014
12/31/2013
12/31/2012
Revenues
(Revenue, Net)
67  
Cost of revenue(4)  
Gross profit:63  
Operating expenses(37)(1)(3)
Other undisclosed operating income  1
Operating income (loss):26(1)(2)
Nonoperating income (expense)(39)(4)1
Investment income, nonoperating 03
Interest and debt expense(0)(0) 
Other undisclosed income from continuing operations before equity method investments, income taxes00 
Loss from continuing operations before income taxes:(13)(5)(1)
Income tax expense (benefit)0(0)(0)
Net loss:(12)(5)(1)
Other undisclosed net loss attributable to parent  (0)
Net loss attributable to parent:(12)(5)(1)
Other undisclosed net income available to common stockholders, basic  0
Net loss available to common stockholders, diluted:(12)(5)(1)

Comprehensive Income ($ in millions)

12/31/2014
12/31/2013
12/31/2012
Net loss:(12)(5)(1)
Comprehensive loss, net of tax, attributable to parent:(12)(5)(1)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: